PISA, Italia, 29 de mayo de 2023 /PRNewswire/ — Abiogen Pharma S.p.A., empresa italiana líder en el campo de las enfermedades osteoarticulares y del metabolismo óseo, se complace en anunciar la adquisición de una participación del 97,09% en EffRx Pharmaceuticals SA, una empresa suiza que…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.